Loading organizations...
§ Venture Capital · Copenhagen, Hovedstaden, Denmark
Innovative therapies for lysosomal storage diseases.
Orphazyme has raised $60.8M across 4 funding rounds.
Key people at Orphazyme.
Orphazyme has raised $60.8M in total across 4 funding rounds.
Orphazyme has raised $60.8M in total across 4 funding rounds.
Orphazyme's investors include Aescap Venture, ALS Investment Fund, Idinvest Partners, Kurma Partners, LSP, Novo Holdings, Sunstone Capital, Rémi Droller, Hakan Goker, Peter Moldt, Sten Verland.
Key people at Orphazyme.
Orphazyme has raised $60.8M across 4 funding rounds. Most recently, it raised $14.9M Series B Extension in March 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 10, 2017 | $14.9M Series B Plus | — | Aescap Venture, ALS Investment Fund, Idinvest Partners, Kurma Partners, LSP, Novo Holdings, Sunstone Capital | Announced |
| Feb 11, 2015 | $22.6M Series B | Rémi Droller | Aescap Venture, Idinvest Partners, Novo Holdings, Sunstone Capital | Announced |
| Sep 9, 2011 | $19.1M Series A | — | Hakan Goker, Peter Moldt, Sunstone Capital | Announced |
| Mar 27, 2011 | $4.2M Seed | Sten Verland | Novo Holdings | Announced |